[en] Several lines of evidence suggest a role for dopamine in the pathophysiology of depression. In 1988, we reported a blunted response of growth hormone (GH) to apomorphine, a dopaminergic agonist, in endogenous depression. However, an antidepressant washout period is a major confounding factor in studies assessing the GH response to apomorphine. Indeed, whereas the influence of tricyclic antidepressants on the GH response to apomorphine is presently unknown, several reports have suggested that tricyclics may impair the GH response to clonidine for periods longer than 3 weeks following their discontinuation. In the present study, we hypothesized that a blunted GH response to apomorphine in depressed patients could be related to the recent administration of antidepressants. Therefore, the GH response to apomorphine (0.5 mg) was studied in 11 male DSM-III-R major depressive inpatients who had never received antidepressant therapy (group 1) compared to 11 normal controls and 11 major depressive inpatients drug free for at least 2 weeks (group 2). The three groups differed significantly in the GH peak response to apomorphine: mean (SD) 5.4 (4.0) ng/ml in group 1, 25.5 (10.7) in normal controls, and 5.5 (5.1) in group 2 (F = 15.5, df = 3, 30, p = 0.00001). While group 1 and normal controls (F = 21.8, p = 0.0002) as well as group 2 and controls (F = 5.6, p = 0.03) differed significantly, group 1 and group 2 did not (F = 0.18, p = 0.68). These results suggest that a washout period of 2 weeks could be sufficient in studies assessing the GH response to apomorphine.
Disciplines :
Psychiatry
Author, co-author :
Pitchot, William ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
Hansenne, Michel ; Université de Liège - ULiège > Département des sciences cognitives > Psycho. de la personnalité et des différences individuelles
Gonzalez Moreno, Antonio; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
Ansseau, Marc ; Centre Hospitalier Universitaire de Liège - CHU > Psychiatrie et psychologie médicale
Language :
English
Title :
Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Kapur S, Mann JJ: Role of the dopaminergic system in depression. Biol Psychiatry 1992;32: 1-17.
Pitchot W, Gonzalez Moreno A, Hansenne M, Wauthy J, Ansseau M: Rôle du systeme dopa-minergique dans la dépression: Corrélats clini-ques du test à l'apomorphine. Acta Psychiatr Belg 1993;93:343-358.
Randrup A, Munkvad I, Fog R: Mania, depression, and brain dopamine; in Essman WB, Val-zelli L (eds): Current Developments in Psychopharmacology. New York, Spectrum Publications, 1975, pp 207-229.
Checkley SA: Neuroendocrine tests of monoamine function in man: A review of basic theory and its application to the study of depressive illness. Psychol Med 1980;10:35-53.
Ansseau M, von Frenckell R, Cerfontaine JL, Papart P, Franck G, Timsit-Bcrthier M, Gee-nen V, Legros JJ: Blunted response of growth hormone to clonidine and apomorphine in endogenous depression. Br J Psychiatry 1988; 153:65-71.
Pitchot W, Hansenne M, Gonzalez Moreno A, Ansseau M: Suicidal behavior and growth hormone response to apomorphine test. Biol Psychiatry 1992:31:1213-1219.
Corn T, Thompson C, Checkley SA: Effects of desipramine treatment upon central adrenore-ceptor function in normal subjects. Br J Psychiatry 1984,145:139-145.
Schittecatte M, Charles G, Machowski R, Wil-motte J: Tricyclic washout and growth hormone response to clonidine. Br J Psychiatry 1989;154:858-863.
Laakmann G: Psychopharmacoendocrinology and depression research. Berlin, Springer, 1990.
Franchimont P: Le dosage radio-immunologi-que de l'hormone de croissance humaine. Cah Méd Lyonnais 1968;44:887-898.
Lai S, Martin JB: Neuroanatomy and neuro-pharmacological regulation of neuroendocrine function; in Van Praag HM, Lader MH, Ra-faelsen OJ, Sachar EJ (eds): Handbook of Biological Psychiatry. III. Brain Mechanisms and Abnormal Behavior-Genetics and Neuroendocrinology. New York, Dekker, 1980.
Hyttel J, OveroKF, Arnt J: Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT uptake inhibitor, citalopram. Psvchopharmacology 1984;83:20-27.
Klimek V. Nielsen M: Chronic treatment with antidepressants decreases the number of [3H]-SCH 23390 binding sites in rat striatum and limbic system. Eur J Pharmacol 1987; 139:163-169
Schittecatte M, Charles G, Nefve C, Garcia Valentin J, Machowski R, Wilmotte J: Longterm downregulation of central adrenoreceptor function by desipramine treatment: A clonidine study in normal subjects. Biol Psychiatry 1992;3:856-858.
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.